62% Upside for Axon? Barclays Thinks So, and Here’s How
Axon Enterprise (AXON) stock dropped 18% to $313 on Nov. 6 after its Q3 report. Barclays cut its price target to $507 from $688, citing delayed federal revenue and reduced free cash flow targets, but maintained an Overweight rating. Revenue grew 28%, but free cash flow fell. Barclays' target implies a 62% upside, based on 2028 earnings estimates.
How this was made
The 30-second read
Why it matters
The downgrade deepens the stock's sell‑off, but the overweight rating suggests some upside if cash flow recovers.
Market read
The analyst target cut provides a fresh catalyst for short‑term traders; the stock already fell sharply on earnings.
What to watch
The $1.2 bn investment in Skydio could drive future revenue growth not reflected in the target.
Background
Barclays reduced its price target for Axon Enterprise following a weaker‑than‑expected Q3 and a sizable cash‑flow shortfall.
Ticker impact
Barclays cut AXON price target to $507 from $688 after its Q3 report, and the stock fell 18% to $313.
likely continued pressure as investors price in the lower target
The target cut is a fresh analyst action on the same day as the earnings release, providing a concrete catalyst for further downside.
Market effects
May weigh on other public safety and defense technology stocks as analysts reassess cash flow expectations.
Limited to U.S. markets; no broader regional effect.
Low; the news is company‑specific.
Counterpoint
If cash flow improves in Q4 as management expects, the target cut could be overdone, offering a buying opportunity.
Key entities
- AnalystBarclays
Equity research firm that cut the price target.
- CompanyAxon Enterprise
Provider of public safety technology.
